Asthma and chronic obstructive pulmonary disease (COPD) are two distinct, chronic, inflammatory respiratory diseases.1,2 Asthma develops early in life, mainly in atopic individuals, and is characterised by airway hyper-responsiveness and recurrent wheezing due to a chronic inflammation of the airways caused by a CD4, T-helper type-2, eosinophilic inflammation.1 COPD develops later in life (age >40 years), in smokers, and is characterised by progressive irreversible airflow obstruction, chronic respiratory symptoms, and chronic inflammation of the airways and the lung caused by a CD8, Tc1, neutrophilic inflammation.

Benralizumab: for asthma, not yet for COPD / Fabbri, Leonardo. - In: THE LANCET RESPIRATORY MEDICINE. - ISSN 2213-2600. - STAMPA. - 2:11(2014), pp. 862-863. [10.1016/S2213-2600(14)70225-5]

Benralizumab: for asthma, not yet for COPD

FABBRI, Leonardo
2014

Abstract

Asthma and chronic obstructive pulmonary disease (COPD) are two distinct, chronic, inflammatory respiratory diseases.1,2 Asthma develops early in life, mainly in atopic individuals, and is characterised by airway hyper-responsiveness and recurrent wheezing due to a chronic inflammation of the airways caused by a CD4, T-helper type-2, eosinophilic inflammation.1 COPD develops later in life (age >40 years), in smokers, and is characterised by progressive irreversible airflow obstruction, chronic respiratory symptoms, and chronic inflammation of the airways and the lung caused by a CD8, Tc1, neutrophilic inflammation.
2014
2
11
862
863
Benralizumab: for asthma, not yet for COPD / Fabbri, Leonardo. - In: THE LANCET RESPIRATORY MEDICINE. - ISSN 2213-2600. - STAMPA. - 2:11(2014), pp. 862-863. [10.1016/S2213-2600(14)70225-5]
Fabbri, Leonardo
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1062129
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact